Research Study of Greater Occipital Nerve Block As A Treatment For Prolonged Migraine Attacks

NCT00329732 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Study terminated due to inadequate recruitment

Conditions

Migraine

Interventions

DRUG: 0.5% bupivicaine and 2% lidocaine
DRUG: Saline placebo

Sponsor

Thomas Jefferson University